Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.verified

SIGY

Price:

$0.039

Market Cap:

$62.61K

Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inf...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

SIGY

The ROE as of June 2026 (TTM) for Sigyn Therapeutics, Inc. (SIGY) is 62.07%

According to Sigyn Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 62.07%. This represents a change of 302.32% compared to the average of 15.43% of the last 4 quarters.

Sigyn Therapeutics, Inc. (SIGY) Historical ROE (quarterly & annually)

How has SIGY ROE performed in the past?

The mean historical ROE of Sigyn Therapeutics, Inc. over the last ten years is 386.82%. The current 62.07% ROE has changed -83.95% with respect to the historical average. Over the past ten years (40 quarters), SIGY's ROE was at its highest in in the December 2015 quarter at 1.53%. The ROE was at its lowest in in the December 2020 quarter at -847.13%.

Quarterly (TTM)
Annual

Average

386.82%

Median

124.34%

Minimum

-1616.01%

Maximum

3.29%

Sigyn Therapeutics, Inc. (SIGY) ROE by Quarter and Year

Discovering the peaks and valleys of Sigyn Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 80.35%

Maximum Annual ROE = 3.29%

Minimum Annual Increase = -1370.48%

Minimum Annual ROE = -1616.01%

Quarterly (TTM)
Annual
YearROEChange
202474.93%-38.32%
2023121.49%-37.71%
2022195.03%-84.84%
20211.29%-179.61%
2020-1616.01%-1370.48%
2019127.20%80.35%
201870.53%-65.26%
2017203.03%68.92%
2016120.19%-96.34%
20153.29%-942.95%

Sigyn Therapeutics, Inc. (SIGY) Average ROE

How has SIGY ROE performed in the past?

The current ROE of Sigyn Therapeutics, Inc. (SIGY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

130.49%

5-year avg

12.38%

10-year avg

386.82%

Sigyn Therapeutics, Inc. (SIGY) ROE vs. Peers

How is SIGY’s ROE compared to its peers?

Sigyn Therapeutics, Inc.’s ROE is greater than Acrux Limited (-211.88%), greater than ProtoKinetix, Incorporated (-116.26%), less than AXIM Biotechnologies, Inc. (4.91%), less than Zelira Therapeutics Limited (56.41%), less than RepliCel Life Sciences Inc. (1.86%), greater than HAVN Life Sciences Inc. (-274.69%), less than Therma Bright Inc. (420.68%), less than Pharmadrug Inc. (28.90%), greater than Core One Labs Inc. (-289.95%), less than IR-Med Inc. (372.24%),

Build a custom stock screener for Sigyn Therapeutics, Inc. (SIGY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigyn Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sigyn Therapeutics, Inc. (SIGY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sigyn Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sigyn Therapeutics, Inc.'s ROE?

How is the ROE calculated for Sigyn Therapeutics, Inc. (SIGY)?

What is the highest ROE for Sigyn Therapeutics, Inc. (SIGY)?

What is the 3-year average ROE for Sigyn Therapeutics, Inc. (SIGY)?

What is the 5-year average ROE for Sigyn Therapeutics, Inc. (SIGY)?

How does the current ROE for Sigyn Therapeutics, Inc. (SIGY) compare to its historical average?